A large body of randomised trials, summarised in systematic reviews, finds St John’s wort superior to placebo and broadly comparable to standard antidepressants for mild to moderate depressive symptoms, with fewer reported side effects. Trials from German-speaking countries report larger effects than those elsewhere, and it has not been shown useful in severe depression. Depression needs clinical assessment, and this is not a self-directed substitute for it.
What may be going on: Hyperforin inhibits reuptake of serotonin, noradrenaline and dopamine, which is also why serotonin syndrome is a real risk in combination with antidepressants.
Strong evidence. Consistent findings across multiple good-quality human studies.
View the 2 sources
- Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.(opens in a new tab)
Meta-analysis · Journal of affective disorders · 2017 · PMID 28064110
- St John's wort for major depression.(opens in a new tab)
Systematic review · The Cochrane database of systematic reviews · 2008 · PMID 18843608
Deep research mode adds each paper’s own conclusion and stated limitations.